{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:57:58Z","timestamp":1792173478672,"version":"4.4.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jsps.2022.02.011","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T07:18:26Z","timestamp":1645773506000},"page":"595-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen"],"prefix":"10.1007","volume":"30","author":[{"given":"Mohammed Ali","family":"Dahhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Alsenaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6","key":"10.1016\/j.jsps.2022.02.011_b0005","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979","volume":"90","author":"Abramova","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jsps.2022.02.011_b0010","first-page":"351","article-title":"Secondary structure analysis of HIV-1-gp41 in solution and adsorbed to aluminum hydroxide by Fourier transform infrared spectroscopy","volume":"1774","author":"Agopian","year":"2007","journal-title":"BBA"},{"issue":"Suppl 3","key":"10.1016\/j.jsps.2022.02.011_b0015","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0264-410X(02)00174-3","article-title":"Design and selection of vaccine adjuvants: animal models and human trials","volume":"20","author":"Alving","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jsps.2022.02.011_b0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/mp900311x","article-title":"In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants","volume":"7","author":"Bachelder","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jsps.2022.02.011_b0025","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/CVI.05556-11","article-title":"Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis","volume":"19","author":"Bellanti","year":"2012","journal-title":"Clin. Vaccine Immunol.: CVI"},{"issue":"31","key":"10.1016\/j.jsps.2022.02.011_b0035","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1016\/j.vaccine.2015.06.037","article-title":"Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination","volume":"33","author":"Bento","year":"2015","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.jsps.2022.02.011_b0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants","volume":"23","author":"Berthold","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccine"},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0050","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/toxins2051038","article-title":"Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin","volume":"2","author":"Bromberg-White","year":"2010","journal-title":"Toxins"},{"issue":"21","key":"10.1016\/j.jsps.2022.02.011_b0055","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0264-410X(00)00031-1","article-title":"Stability of aluminium-containing adjuvants during aging at room temperature","volume":"18","author":"Burrell","year":"2000","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.jsps.2022.02.011_b0060","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M116.753301","article-title":"Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting","volume":"291","author":"Chen","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/CVI.00792-14","article-title":"Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine","volume":"22","author":"Chi","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-065X.2010.00969.x","article-title":"Progress and novel strategies in vaccine development and treatment of anthrax","volume":"239","author":"Chitlaru","year":"2011","journal-title":"Immunol. Rev."},{"issue":"19","key":"10.1016\/j.jsps.2022.02.011_b0075","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1016\/j.vaccine.2020.02.001","article-title":"Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation","volume":"38","author":"Colaprico","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/glycob\/cwq201","article-title":"Delta inulin: a novel, immunologically active, stable packing structure comprising \u03b2-D-[2 -> 1] poly(fructo-furanosyl) \u03b1-D-glucose polymers","volume":"21","author":"Cooper","year":"2011","journal-title":"Glycobiology"},{"issue":"Pt 1","key":"10.1016\/j.jsps.2022.02.011_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"Cristillo","year":"2011","journal-title":"J. Gen. Virol."},{"issue":"23","key":"10.1016\/j.jsps.2022.02.011_b0090","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1073\/pnas.1002348107","article-title":"Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax","volume":"107","author":"Datta","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0095","doi-asserted-by":"crossref","first-page":"e61825","DOI":"10.1371\/journal.pone.0061825","article-title":"A randomized, observer-blinded immunogenicity trial of Cervarix(\u00ae) and Gardasil(\u00ae) Human Papillomavirus vaccines in 12\u201315 year old girls","volume":"8","author":"Draper","year":"2013","journal-title":"PLoS ONE"},{"issue":"7-8","key":"10.1016\/j.jsps.2022.02.011_b0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/CVI.00019-14","article-title":"Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant","volume":"21","author":"Feinen","year":"2014","journal-title":"Clin. Vaccine Immunol.: CVI"},{"issue":"20","key":"10.1016\/j.jsps.2022.02.011_b0110","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/adhm.201600642","article-title":"Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure","volume":"5","author":"Gallovic","year":"2016","journal-title":"Adv. Healthcare Mater."},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0920-5861(92)80021-E","article-title":"Amorphous aluminum phosphate gels","volume":"14","author":"Glemza","year":"1992","journal-title":"Catal. Today"},{"issue":"27","key":"10.1016\/j.jsps.2022.02.011_b0120","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/j.vaccine.2011.03.082","article-title":"A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax","volume":"29","author":"Gorantala","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.02.011_b0125","series-title":"Aluminum Compounds as Vaccine Adjuvants. Vaccine Adjuvants","first-page":"65","author":"Gupta","year":"2000"},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/md11020363","article-title":"Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharides","volume":"11","author":"Han","year":"2013","journal-title":"Mar. Drugs"},{"issue":"8","key":"10.1016\/j.jsps.2022.02.011_b0135","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/jps.22555","article-title":"Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response","volume":"100","author":"Hansen","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"2\u20133","key":"10.1016\/j.jsps.2022.02.011_b0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.micron.2011.07.012","article-title":"Alhydrogel(R) adjuvant, ultrasonic dispersion and protein binding: a TEM and analytical study","volume":"43","author":"Harris","year":"2012","journal-title":"Micron"},{"key":"10.1016\/j.jsps.2022.02.011_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4615-1823-5_9","article-title":"Structure and properties of aluminum-containing adjuvants","volume":"6","author":"Hem","year":"1995","journal-title":"Pharm. Biotechnol."},{"issue":"37","key":"10.1016\/j.jsps.2022.02.011_b0150","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"npj Vaccines"},{"key":"10.1016\/j.jsps.2022.02.011_b0160","doi-asserted-by":"crossref","unstructured":"Holmgren, J., Harandi, A.M., Lebens, M., Sun, J.-B., Anju\u00e8re, F., Czerkinsky, C., 2006. 14 \u2013 Mucosal adjuvants based on cholera toxin and E. coli heat-labile enterotoxin. In: Schijns, V.E.J.C., O'Hagan, D.T. (Eds.), Immunopotentiators in Modern Vaccines. London, Academic Press, pp. 235\u2013252.","DOI":"10.1016\/B978-012088403-2\/50015-0"},{"issue":"18","key":"10.1016\/j.jsps.2022.02.011_b0165","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.vaccine.2016.03.006","article-title":"Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults","volume":"34","author":"Hopkins","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.02.011_b0170","doi-asserted-by":"crossref","unstructured":"Hsu, P., 1989. luminium hydroxides and oxyhydroxides. In: Dixon, J.B., Weed, S.B. (Eds.), Minerals in soil environments. Madison, WI: Soil Science Society of America, pp. 331\u2013378.","DOI":"10.2136\/sssabookser1.2ed.c7"},{"issue":"21\u201322","key":"10.1016\/j.jsps.2022.02.011_b0175","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(03)00109-9","article-title":"Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants","volume":"21","author":"Jendrek","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.02.011_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4236\/wjv.2011.13008","article-title":"Recent developments in the nasal immunization against anthrax","volume":"1","author":"Jesus","year":"2011","journal-title":"World J. Vaccine"},{"issue":"10","key":"10.1016\/j.jsps.2022.02.011_b0185","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.vaccine.2005.09.048","article-title":"Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid","volume":"24","author":"Jiang","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jsps.2022.02.011_b0190","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jps.10166","article-title":"Measuring the surface area of aluminum hydroxide adjuvant","volume":"91","author":"Johnston","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"14","key":"10.1016\/j.jsps.2022.02.011_b0195","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.M500687200","article-title":"Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens","volume":"280","author":"Jones","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0200","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.1501903","article-title":"A CpG-Ficoll nanoparticle adjuvant for anthrax protective antigen enhances immunogenicity and provides single-immunization protection against inhaled anthrax in monkeys","volume":"196","author":"Kachura","year":"2016","journal-title":"J. Immunol."},{"issue":"7335","key":"10.1016\/j.jsps.2022.02.011_b0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jsps.2022.02.011_b0210","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/acs.jpca.7b12348","article-title":"Deamidation of protonated asparagine-valine investigated by a combined spectroscopic, guided ion beam, and theoretical study","volume":"122","author":"Kempkes","year":"2018","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jsps.2022.02.011_b0215","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"issue":"2\u20133","key":"10.1016\/j.jsps.2022.02.011_b0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(85)90687-9","article-title":"Histamine release induced from mast cells by active components of compound 48\/80","volume":"115","author":"Koibuchi","year":"1985","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jsps.2022.02.011_b0225","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/14760584.2019.1643242","article-title":"Vaccines against anthrax based on recombinant protective antigen: problems and solutions","volume":"18","author":"Kondakova","year":"2019","journal-title":"Expert Rev. Vaccine"},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.jsps.2022.02.011_b0235","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00240-12","article-title":"Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax","volume":"19","author":"Leffel","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"10","key":"10.1016\/j.jsps.2022.02.011_b0240","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 6","key":"10.1016\/j.jsps.2022.02.011_b0245","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","article-title":"An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses","volume":"91","author":"Lobigs","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jsps.2022.02.011_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00562","article-title":"Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax","volume":"9","author":"Malik","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jsps.2022.02.011_b0255","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1371\/journal.ppat.0030142","article-title":"A viral nanoparticle with dual function as an anthrax antitoxin and vaccine","volume":"3","author":"Manayani","year":"2007","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0260","doi-asserted-by":"crossref","first-page":"e61885","DOI":"10.1371\/journal.pone.0061885","article-title":"A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge","volume":"8","author":"Manish","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.jsps.2022.02.011_b0265","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vaccine.2015.11.025","article-title":"Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine","volume":"34","author":"McComb","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jsps.2022.02.011_b0280","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/JB.183.6.2111-2116.2001","article-title":"Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin","volume":"183","author":"Mogridge","year":"2001","journal-title":"J. Bacteriol."},{"issue":"31","key":"10.1016\/j.jsps.2022.02.011_b0285","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0264-410X(01)00193-1","article-title":"Towards the rational design of Th1 adjuvants","volume":"19","author":"Moingeon","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.02.011_b0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coi.2017.07.010","article-title":"Towards an evidence based approach for the development of adjuvanted vaccines","volume":"47","author":"O\u2019Hagan","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"20","key":"10.1016\/j.jsps.2022.02.011_b0295","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1128\/JB.181.20.6509-6515.1999","article-title":"Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes","volume":"181","author":"Okinaka","year":"1999","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/CVI.05376-11","article-title":"Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores","volume":"19","author":"Peachman","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"6619","key":"10.1016\/j.jsps.2022.02.011_b0305","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jsps.2022.02.011_b0310","unstructured":"Plotkin, S.A., Orenstein, W., Offit, P.A., Edwards, K.M., 2017. Vaccines E-Book, Elsevier Health Sciences."},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0315","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/prot.21432","article-title":"Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity","volume":"68","author":"Powell","year":"2007","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0320","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.jim.7000239","article-title":"Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis","volume":"28","author":"Ramirez","year":"2002","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0325","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2010.11.049","article-title":"Highly effective generic adjuvant systems for orphan or poverty-related vaccines","volume":"29","author":"Rao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.02.011_b0330","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/toxins3080979","article-title":"Mechanism of Lethal Toxin Neutralization by a Human Monoclonal Antibody Specific for the PA20 Region of Bacillus anthracis Protective Antigen","volume":"3","author":"Reason","year":"2011","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.jsps.2022.02.011_b0335","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/toxins3080979","article-title":"Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen","volume":"3","author":"Reason","year":"2011","journal-title":"Toxins (Basel)"},{"issue":"12","key":"10.1016\/j.jsps.2022.02.011_b0340","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"33","key":"10.1016\/j.jsps.2022.02.011_b0345","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsps.2022.02.011_b0350","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0355","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0952-7915(00)00120-5","article-title":"Immunological concepts of vaccine adjuvant activity: commentary","volume":"12","author":"Schijns","year":"2000","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0360","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s11095-013-0975-x","article-title":"Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis","volume":"30","author":"Schully","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jsps.2022.02.011_b0365","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2015.03.057","article-title":"Gaps in knowledge and prospects for research of adjuvanted vaccines","volume":"33","author":"Seder","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0370","first-page":"115","article-title":"Helicobacter pylori vaccine : mucosal adjuvant & delivery systems","volume":"130","author":"Sijun","year":"2009","journal-title":"Indian J. Med. Res."},{"issue":"4","key":"10.1016\/j.jsps.2022.02.011_b0375","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Human Vaccines Immunother."},{"issue":"32","key":"10.1016\/j.jsps.2022.02.011_b0380","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","article-title":"A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo","volume":"264","author":"Singh","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jsps.2022.02.011_b0385","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of Immunization against Anthrax with the Purified Recombinant Protective Antigen of <em>Bacillus anthracis<\/em>","volume":"66","author":"Singh","year":"1998","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.jsps.2022.02.011_b0390","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-006-0206-9","article-title":"Nasal Immunization with Anthrax Protective Antigen Protein Adjuvanted with Polyriboinosinic-Polyribocytidylic Acid Induced Strong Mucosal and Systemic Immunities","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jsps.2022.02.011_b0395","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1574-695X.2007.00347.x","article-title":"Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens","volume":"52","author":"Sloat","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2011.09.009","article-title":"Anthrax sub-unit vaccine: The structural consequences of binding rPA83 to Alhydrogel\u00ae","volume":"80","author":"Soliakov","year":"2012","journal-title":"Eur. J. Pharmac. Biopharmac.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.jsps.2022.02.011_b0405","unstructured":"Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep, vol. 50, no. 41, p. 889\u2013993."},{"issue":"6","key":"10.1016\/j.jsps.2022.02.011_b0410","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/bm200369e","article-title":"Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies","volume":"12","author":"Venter","year":"2011","journal-title":"Biomacromolecules"},{"issue":"43","key":"10.1016\/j.jsps.2022.02.011_b0415","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.vaccine.2018.09.012","article-title":"Improving the stability of recombinant anthrax protective antigen vaccine","volume":"36","author":"Verma","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0420","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/IAI.00863-12","article-title":"Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of bacillus anthracis protective antigen","volume":"81","author":"Verma","year":"2013","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.jsps.2022.02.011_b0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.00701-15","article-title":"Mechanistic analysis of the effect of deamidation on the immunogenicity of anthrax protective antigen","volume":"23","author":"Verma","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"9","key":"10.1016\/j.jsps.2022.02.011_b0430","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00174-12","article-title":"Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant","volume":"19","author":"Wagner","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0435","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jps.22742","article-title":"Stable dry powder formulation for nasal delivery of anthrax vaccine","volume":"101","author":"Wang","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.jsps.2022.02.011_b0440","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/CVI.00320-13","article-title":"Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactions","volume":"20","author":"Watkinson","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.02.011_b0445","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/IAI.74.1.394-398.2006","article-title":"Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume":"74","author":"Weiss","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jsps.2022.02.011_b0450","doi-asserted-by":"crossref","first-page":"e2686","DOI":"10.7717\/peerj.2686","article-title":"Reanalysis of the anthrax epidemic in Rhodesia, 1978\u20131984","volume":"4","author":"Wilson","year":"2016","journal-title":"PeerJ"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016422000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016422000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:27:54Z","timestamp":1736184474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016422000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1319016422000524"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2022.02.011","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2022.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}